Brexit Won’t Alter EU Agency Heads’ Ambitious Work Plan – For Now

Europe’s medicines agency heads say they are pressing on as planned with the priorities and activities in the joint “strategy to 2020” they have with the European Medicines Agency. But this could change and, in any case, more resources are needed and agencies need to engage more to support delivery of their plan.

Brexit concept
European regulators are pressing on with their priorities as planned

Europe's Heads of Medicines Agencies grouping has confirmed that – for now at least – it is not scrapping or changing any of the 11 priority areas or 63 corresponding actions in its ambitious multiannual work plan in light of Brexit. Some changes are inevitable, but at present the plan remains unchanged. That’s according to Estonia’s top medicines regulator Kristin Raudsepp.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

More from Geography